- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06327009
Effect of Ramadan Fasting on Kidney Function and Proteinuria in Patients With Glomerulonephritis
June 15, 2024 updated by: Mohamed Mamdouh Mahmoud Mohamed Elsayed , MD, Alexandria University
Effect of Ramadan Fasting on Kidney Function and Proteinuria in Patients With Glomerulonephritis: a Prospective Observational Clinical Trial
This research aims to assess effects of ramadan fasting on kidney function and proteinuria in patients with glomerulonephritis.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Fasting from sunrise to sunset during the Islamic holy month of Ramadan is one of the five pillars of the Islamic faith.
Duration of the fasting ranges from 10 to 18 hours per day according to the geographic location and the season.
Although people with chronic illnesses are exempted from fasting according to Islamic beliefs, many patients insist on fasting against medical advice.
Through the last three decades many reports studied the potential risks and benefits of fasting Ramadan in regular hemodialysis (HD) patients.
Target points of investigation were different.
Most of them were focusing on the electrolytes and nutritional changes.
Fewer reports tested the mortality rate.
In a multicenter observational study, 2055 Egyptian patients from 25 HD units were studied for frequency of fasting in Ramadan and the possible effect of fasting on clinical and biochemical variables.
The investigators concluded that nearly 47% of the study patients fasted at least few days of Ramadan.
They recommended that HD patients should be encouraged to discuss the option of fasting in Ramadan with their HD staff who might be able to give advice on whether to allow them to fast in days off dialysis with special precautions regarding associated comorbidities, especially diabetes and coronary artery disease.
Most of the studies focused on the effects of fasting the month of Ramadan in CKD and hemodialysis patients, but no research assessed these effects specifically in patients with glomerulonephritis.
Study Type
Observational
Enrollment (Actual)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Alexandria, Egypt, 21526
- Faculty of Medicine, Aexandria University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
one hundred patients with biopsy proven glomerulonephritis for more than 3 months from different centers in Egypt will be enrolled in the study
Description
Inclusion Criteria:
- Patients with biopsy proven glomerulonephritis with eGFR ≥ 30 ml/min for more than 3 months (exception is nephrotic patients with positive anti-PLA2R indicative of primary membranous).
Exclusion Criteria:
- Patients with medical contraindications for fasting.
- Patients with eGFR < 30 ml/min.
- Patients with acute cardiovascular disease.
- uncontrolled diabetes mellitus.
- active or chronic inflammatory disease.
- Acute liver disease.
- Pregnancy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
fasting
100 patients who decided to fast the month of ramadan.
|
100 patients with glomerulonephritis who decided to fast month of ramadan
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in kidney function
Time Frame: 4 weeks (month of ramadan)
|
By assessing change in eGFR
|
4 weeks (month of ramadan)
|
|
Change in proteinuria
Time Frame: 4 weeks (month of ramadan)
|
By assessing change in protein to creatinine ratio in urine
|
4 weeks (month of ramadan)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Mohamed Mamdouh Elsayed, MD, Assistant Professor
- Study Chair: kariem M salem, MD, lecturer
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Sahin SB, Ayaz T, Ozyurt N, Ilkkilic K, Kirvar A, Sezgin H. The impact of fasting during Ramadan on the glycemic control of patients with type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2013 Oct;121(9):531-4. doi: 10.1055/s-0033-1347247. Epub 2013 Aug 9.
- Megahed AF, El-Kannishy G, Sayed-Ahmed N. Status of fasting in Ramadan of chronic hemodialysis patients all over Egypt: A multicenter observational study. Saudi J Kidney Dis Transpl. 2019 Mar-Apr;30(2):339-349. doi: 10.4103/1319-2442.256841.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 22, 2024
Primary Completion (Actual)
April 22, 2024
Study Completion (Actual)
June 14, 2024
Study Registration Dates
First Submitted
March 12, 2024
First Submitted That Met QC Criteria
March 15, 2024
First Posted (Actual)
March 25, 2024
Study Record Updates
Last Update Posted (Actual)
June 18, 2024
Last Update Submitted That Met QC Criteria
June 15, 2024
Last Verified
June 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- fasting ramadan in GN patients
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fasting Ramadan
-
University of GuelphCompletedRamadan FastingCanada
-
Imperial College London Diabetes CentreUnknownEnergy Expenditure During Ramadan FastingUnited Arab Emirates
-
Hartford HospitalShaare Zedek Medical CenterCompletedHeadache | Fasting | Fasting Headache | Ramadan HeadacheIsrael
-
Sohag UniversityCompletedDifferent Regimens in Treatment of Hypothyroidism During Fasting in RamadanEgypt
-
Sohag UniversityCompletedType2 Diabetes | SGLT2 Inhibitors, First Time Use | Fasting in RamadanEgypt
-
University Tunis El ManarHopital La RabtaActive, not recruitingFasting, Intermittent | Inflammatory Markers | Diabetes Mellitus, Type 2 Treated With Insulin | Ramadan FastingTunisia
-
University of MichiganCompletedWeight Loss | Aerobic Exercise | Obesity & Overweight | Ramadan FastingUnited States
-
Hopital La RabtaNot yet recruitingDehydration | Primary Adrenal Insufficiency | Prednisolone | Continuous Glucose Monitoring | Hypoglycemia Non-Diabetic | Ramadan FastingTunisia
-
University of BariCompleted
-
University of ChileAgencia Nacional de Investigación y DesarrolloCompletedIntermittent Fasting in Shift-workChile
Clinical Trials on fasting month of ramadan
-
Dilan aktepe coşarGümüşhane UniversıtyNot yet recruitingType 2 DiabetesTurkey (Türkiye)
-
Abant Izzet Baysal UniversityCompletedSleep | Food Habits | Fasting, IntermittentTurkey
-
Free Islamic University of Medical SciencesCompletedMetabolic Syndrome
-
Hopital La RabtaNot yet recruitingDehydration | Primary Adrenal Insufficiency | Prednisolone | Continuous Glucose Monitoring | Hypoglycemia Non-Diabetic | Ramadan FastingTunisia
-
Universität Duisburg-EssenCompleted
-
Universitas DiponegoroCompletedFasting | Gut HormoneIndonesia
-
Ain Shams UniversityCompletedLiver TransplantationEgypt
-
Free Islamic University of Medical SciencesCompleted
-
Hopital La RabtaCompletedIntermittent Fasting | Primary Adrenal InsufficiencyTunisia
-
Bastyr UniversityRecruiting